Today: 21 May 2026
Browse Category

NYSE:XYZ 6 November 2025 - 7 December 2025

XYZ Stock (Block Inc) Forecast December 2025: BNPL Probe, Holiday Spending and Wall Street’s Outlook

XYZ Stock (Block Inc) Forecast December 2025: BNPL Probe, Holiday Spending and Wall Street’s Outlook

Block, Inc. shares fell to $61.11 at the December 5 close, down 16% over the past month, after U.S. state regulators launched a probe into Afterpay and other BNPL firms. Despite the slide, Block posted strong Q3 earnings and double-digit holiday transaction growth. The company’s market cap stands near $37 billion, with a P/E ratio around 12.3.
7 December 2025
··
Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block, Inc. shares fell 6.6% to close at $60.11 on December 2, 2025, despite reporting record Black Friday–Cyber Monday volumes. The company processed over 124 million transactions, up 10% year-over-year, but trading volume surged to 20.7 million shares, nearly triple the 30-day average. Block’s market cap stands at about $39 billion, well below its 52-week high.
3 December 2025
·
Block (XYZ) Stock Slides After Q3 Miss, But Guidance Ticks Higher — What Investors Need to Know Today (Nov 6, 2025)

XYZ Stock Jumps as Block Unveils $5 Billion Buyback and Bullish 2028 Outlook at Investor Day

Block Inc. shares jumped over 8% to near $62 Wednesday after the company announced a $5 billion share buyback and issued detailed financial targets through 2028 at its San Francisco Investor Day. Block projected gross profit to reach $15.8 billion and adjusted EPS to hit $5.50 by 2028. The stock is up more than 30% year to date. Market cap stands at about $35 billion.
19 November 2025
·
Block (XYZ) Stock Slides After Q3 Miss, But Guidance Ticks Higher — What Investors Need to Know Today (Nov 6, 2025)

Block (XYZ) Stock Slides After Q3 Miss, But Guidance Ticks Higher — What Investors Need to Know Today (Nov 6, 2025)

Block, Inc. (NYSE: XYZ) missed third-quarter estimates, posting adjusted EPS of $0.54 and revenue of $6.11B, both below forecasts, sending shares down 10%–13% after hours. The company raised its 2025 gross profit outlook to about $10.24B. GAAP net income was $461.5M. Investors focused on the modest EBIT beat and concerns about operating leverage.
6 November 2025
··

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Go toTop